Point72 Asset Management’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$372K Buy
98,738
+55,832
+130% +$301K ﹤0.01% 3271
2025
Q4
$340K Buy
+42,906
New +$274K ﹤0.01% 3424
2024
Q2
Sell
-202,700
Closed -$1.07M 2388
2024
Q1
$1.07M Buy
202,700
+9,699
+5% +$45.6K ﹤0.01% 1451
2023
Q4
$996K Buy
193,001
+40,101
+26% +$124K ﹤0.01% 1399
2023
Q3
$515K Buy
152,900
+152,888
+1,274,067% +$1M ﹤0.01% 1500
2023
Q2
$99 Sell
12
-6,237
-100% -$56.2K ﹤0.01% 2058
2023
Q1
$54.6K Buy
+6,249
New +$69.4K ﹤0.01% 1765
2022
Q4
Sell
-195,600
Closed -$1.24M 1763
2022
Q3
$1.24M Buy
+195,600
New +$1.65M 0.01% 1017
2021
Q4
Sell
-48,400
Closed -$1.1M 1279
2021
Q3
$1.1M Buy
+48,400
New +$1.59M ﹤0.01% 845

Other funds holding SGHT

Point72 Asset Management's SGHT Position: Q1 2026 in Review

Point72 Asset Management increased its Sight Sciences (SGHT) stake by 130% in Q1 2026, buying an estimated $301K and bringing the position to 98,738 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #3271.

Point72 Asset Management first reported a position in SGHT in Q3 2021 and has held it in 9 quarters since. The position peaked at $1.24M in Q3 2022. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Point72 Asset Management held 98,738 shares of Sight Sciences worth $372K as of Q1 2026.
  • Point72 Asset Management bought 55,832 Sight Sciences shares in Q1 2026, an estimated $301K.
  • Sight Sciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3271 holding.
  • Point72 Asset Management first reported a position in Sight Sciences in Q3 2021 and has held it in 9 quarters since.
  • Point72 Asset Management's Sight Sciences position peaked at $1.24M in Q3 2022.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.